tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline

C134H188F3N35O16S6 — CID 157122107

About tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline

tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline (PubChem CID 157122107) has the molecular formula C134H188F3N35O16S6 and a molecular weight of 2794.60 g/mol. Its IUPAC name is tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline.

Molecular Properties

• Compound Name: tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline
• PubChem CID: 157122107
• Molecular Formula: C134H188F3N35O16S6
• Molecular Weight: 2794.60 g/mol
• Exact Mass: 2792.32
• IUPAC Name: tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline
• SMILES: CCN(C)S(=O)(=O)c1cccc(NC)c1.CCNS(=O)(=O)c1cccc(NC)c1.CCNS(=O)(=O)c1cccc(NC)c1.CCNS(=O)(=O)c1cccc(NC)c1.CCS(=O)(=O)N(CC(=O)N(C)C)c1cccc(NC)c1.CNC(=O)c1cc(NC)cc(C(F)(F)F)c1.CNc1cccc(-c2ccn(C)n2)c1.CNc1cccc(-c2ncn[nH]2)c1.CNc1cccc(-c2nnnn2C)c1.CNc1cccc(N2CCCCC2)c1.CNc1cccc(N2CCN(C)C2=O)c1.CNc1cccc(N2CCNC2=O)c1.CNc1cccc(S(=O)(=O)N2CCCCC2)c1
• InChI: InChI=1S/C13H21N3O3S.C12H18N2O2S.C12H18N2.C11H15N3O.C11H13N3.C10H11F3N2O.C10H13N3O.C10H16N2O2S.C9H11N5.C9H10N4.3C9H14N2O2S/c1-5-20(18,19)16(10-13(17)15(3)4)12-8-6-7-11(9-12)14-2;1-13-11-6-5-7-12(10-11)17(15,16)14-8-3-2-4-9-14;1-13-11-6-5-7-12(10-11)14-8-3-2-4-9-14;1-12-9-4-3-5-10(8-9)14-7-6-13(2)11(14)15;1-12-10-5-3-4-9(8-10)11-6-7-14(2)13-11;1-14-8-4-6(9(16)15-2)3-7(5-8)10(11,12)13;1-11-8-3-2-4-9(7-8)13-6-5-12-10(13)14;1-4-12(3)15(13,14)10-7-5-6-9(8-10)11-2;1-10-8-5-3-4-7(6-8)9-11-12-13-14(9)2;1-10-8-4-2-3-7(5-8)9-11-6-12-13-9;3*1-3-11-14(12,13)9-6-4-5-8(7-9)10-2/h6-9,14H,5,10H2,1-4H3;5-7,10,13H,2-4,8-9H2,1H3;5-7,10,13H,2-4,8-9H2,1H3;3-5,8,12H,6-7H2,1-2H3;3-8,12H,1-2H3;3-5,14H,1-2H3,(H,15,16);2-4,7,11H,5-6H2,1H3,(H,12,14);5-8,11H,4H2,1-3H3;3-6,10H,1-2H3;2-6,10H,1H3,(H,11,12,13);3*4-7,10-11H,3H2,1-2H3
• InChIKey: AIBYRRQCVBSNBH-UHFFFAOYSA-N
• XLogP: 19.57
• TPSA: 618.57 Ų
• H-Bond Donors: 19
• H-Bond Acceptors: 38
• Rotatable Bonds: 39
• Heavy Atoms: 194
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2794.60
LogP ≤ 5	19.57
H-Bond Donors ≤ 5	19
H-Bond Acceptors ≤ 10	38

Frequently Asked Questions

What is the IUPAC name of tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline?

The IUPAC name of tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline (CID 157122107) is tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline.

What is the SMILES notation for tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline?

The canonical SMILES for tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline is CCN(C)S(=O)(=O)c1cccc(NC)c1.CCNS(=O)(=O)c1cccc(NC)c1.CCNS(=O)(=O)c1cccc(NC)c1.CCNS(=O)(=O)c1cccc(NC)c1.CCS(=O)(=O)N(CC(=O)N(C)C)c1cccc(NC)c1.CNC(=O)c1cc(NC)cc(C(F)(F)F)c1.CNc1cccc(-c2ccn(C)n2)c1.CNc1cccc(-c2ncn[nH]2)c1.CNc1cccc(-c2nnnn2C)c1.CNc1cccc(N2CCCCC2)c1.CNc1cccc(N2CCN(C)C2=O)c1.CNc1cccc(N2CCNC2=O)c1.CNc1cccc(S(=O)(=O)N2CCCCC2)c1.

What is the InChIKey of tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline?

The InChIKey is AIBYRRQCVBSNBH-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H21N3O3S.C12H18N2O2S.C12H18N2.C11H15N3O.C11H13N3.C10H11F3N2O.C10H13N3O.C10H16N2O2S.C9H11N5.C9H10N4.3C9H14N2O2S/c1-5-20(18,19)16(10-13(17)15(3)4)12-8-6-7-11(9-12)14-2;1-13-11-6-5-7-12(10-11)17(15,16)14-8-3-2-4-9-14;1-13-11-6-5-7-12(10-11)14-8-3-2-4-9-14;1-12-9-4-3-5-10(8-9)14-7-6-13(2)11(14)15;1-12-10-5-3-4-9(8-10)11-6-7-14(2)13-11;1-14-8-4-6(9(16)15-2)3-7(5-8)10(11,12)13;1-11-8-3-2-4-9(7-8)13-6-5-12-10(13)14;1-4-12(3)15(13,14)10-7-5-6-9(8-10)11-2;1-10-8-5-3-4-7(6-8)9-11-12-13-14(9)2;1-10-8-4-2-3-7(5-8)9-11-6-12-13-9;3*1-3-11-14(12,13)9-6-4-5-8(7-9)10-2/h6-9,14H,5,10H2,1-4H3;5-7,10,13H,2-4,8-9H2,1H3;5-7,10,13H,2-4,8-9H2,1H3;3-5,8,12H,6-7H2,1-2H3;3-8,12H,1-2H3;3-5,14H,1-2H3,(H,15,16);2-4,7,11H,5-6H2,1H3,(H,12,14);5-8,11H,4H2,1-3H3;3-6,10H,1-2H3;2-6,10H,1H3,(H,11,12,13);3*4-7,10-11H,3H2,1-2H3.

What are the key properties of tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline?

tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline has a molecular weight of 2794.60 g/mol, XLogP of 19.57, 39 rotatable bonds, 19 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for tris(N-ethyl-3-(methylamino)benzenesulfonamide);N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;1-[3-(methylamino)phenyl]imidazolidin-2-one;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(methylamino)-5-(trifluoromethyl)benzamide;N-methyl-3-(1-methylpyrazol-3-yl)aniline;N-methyl-3-(1-methyltetrazol-5-yl)aniline;N-methyl-3-piperidin-1-ylaniline;N-methyl-3-piperidin-1-ylsulfonylaniline;N-methyl-3-(1H-1,2,4-triazol-5-yl)aniline is sourced from PubChem (CID 157122107), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).